Industry Pipeline - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Industry Pipeline
Interphex Showcase 2010.

Pharmaceutical Technology
Volume 34, Issue 4, pp. 128-135



Manufacturing capabilities
Lyne Laboratories offers its explosion-proof manufacturing capabilities for high-concentration, flammable pharmaceuticals. Lyne's state-of-the-art facility was designed specifically for formulations high in alcohol content and for solvent-based drug products. Batch sizes range from 1000 to 8000 L. Lyne is registered with the US Food and Drug Administration and licensed by the Drug Enforcement Administration. Lyne Laboratories, Brockton, MA http://www.lyne.com/ tel. 800.525.0450



Contract Services
Chemic Laboratories is a contract facility that follows good manufacturing and laboratory practices. The company offers extractables-leachables analysis, methods development and validations, bioanalytical services, organic synthesis and formulation development, and stability testing. The independent Chemic Consulting Consortium advises clients throughout their product-development cycles. Chemic Laboratories, Canton, MA http://www.chemiclabs.com/ tel. 781.821.5600



Contract services
Mikart has provided contract development, manufacturing, and packaging services to the pharmaceutical industry since 1975. The company's capabilities include formulation development; analytical services; solid- and liquid-dose manufacturing; packaging in bottles, blisters, and multilaminate pouches; project management; and regulatory services. Mikart, Atlanta, GA http://www.mikart.com/ tel. 888.4MIKART



Drug-delivery solutions
For more than 50 years, companies have looked to 3M Drug Delivery Systems for solutions to help their products meet the market's needs. 3M offers inhalation and transdermal drug-delivery systems and components, including dry-powder inhaler and microneedle technologies, plus state-of-the-art contract manufacturing services to help ensure technical success. 3M Drug Delivery Systems, St. Paul, MN http://www.3m.com/ tel. 800.643.8086


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
How does your company apply quality-by-design (QbD) principles to manufacturing processes?
To all processes for both new and legacy products
To all process for new products only
To select process for new products only
To select processes for both new and legacy products
Do not use QbD
To all processes for both new and legacy products
20%
To all process for new products only
13%
To select process for new products only
24%
To select processes for both new and legacy products
20%
Do not use QbD
22%
View Results
UPCOMING CONFERENCES

Programs for Investigational and Pre-Launch Drugs
Philadelphia, PA
July 17-18, 2013
Request Brochure

Strategic Pipeline Planning & Portfolio Valuation
Philadelphia, PA
August 13-14, 2013
Request Brochure

MES 2013 - Forum on Manufacturing Execution Systems
Philadelphia, PA
August 14-15, 2013
Request Brochure

Mobile Innovation for the Life Sciences Industry
Philadelphia, PA
August 20-21, 2013
Request Brochure

See All Conferences >>

Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
Inadequate Access to Medicines Puts EU at Risk
FDA Offers Insight on QbD for Modified-Release Products
Global Biosimilars Market to Reach $2.445 Billion in 2013
Adapting to Change
AstraZeneca and Exco InTouch Collaborate to Augment Current COPD Pathways
FindPharma Custom Search
Source: Pharmaceutical Technology,
Click here